Articles tagged "Outcome"

2018 American Transplant Congress
Digital-Enabled Refills and Medication Adherence among Transplant Recipients
S. Boghani, H. Kirkham, G. Pietradoni, N. Hira.
Walgreen Co., Deerfield, IL.
Purpose: Impact of nonadherence among transplant recipients has been well documented as a significant contributor of allograft failure. The objective of this study was to…
2018 American Transplant Congress
As Clear as Mud: Volatility of the Five-Tier Quality Assessment of Kidney Transplant Centers in the United States
J. Schold,¹ K. Andreoni,² A. Chandraker,³ R. Gaston,⁴ J. Locke,⁴ A. Mathur,⁵ T. Pruett,⁶ A. Rana,⁷ L. Ratner,⁸ L. Buccini.¹
¹Cleveland Clinic, Cleveland; ²University of Florida, Gainesville; ³Harvard Medical School, Boston; ⁴University of Alabama at Birmingham, Birmingham; ⁵Mayo Clinic, Phoenix; ⁶University of Minnesota, Minneapolis; ⁷Baylor College of Medicine, Houston; ⁸Columbia University, New York.
Outcomes of patients receiving transplants in the US are systematically aggregated into bi-annual Program-Specific Reports(PSRs) detailing risk-adjusted survival by transplant center. Recently the SRTR issued…
2018 American Transplant Congress
Regression of Left Atrial Diameter after Kidney Transplantation is Associated with Prolonged Survival: An Observational Study
A. Kainz,¹ F. Regele,¹ M. Kammer,² A. Beer,³ R. Steringer-Mascherbauer,⁴ T. Binder,⁵ R. Oberbauer.¹
¹Nephrology, Medical University of Vienna, Vienna, Austria; ²CeMSIIS, Medical University of Vienna, Vienna, Austria; ³Nephrology, Medical University of Innsbruck, Innsbruck, Austria; ⁴Cardiology, Ordensklinikum Linz, Linz, Austria; ⁵Cardiology, Medical University of Vienna, Vienna, Austria.
BackgroundThe risk of cardiovascular death in patients on dialysis is dramatically elevated but can be reduced by renal transplantation. We previously showed that left atrial…
2018 American Transplant Congress
Associations of Poor Physical and Cognitive Performance and Kidney Transplant Waiting List Denial
M. Harhay,¹ K. Ranganna,¹ F. Michie,¹ C. Selinski,¹ T. Bajakian,¹ L. Levin Mizrahi,¹ J. Lee,¹ G. Malat,¹ G. Xiao,¹ D. Reich,¹ S. Guy,¹ P. Reese.²
¹Drexel University College of Medicine, Philadelphia; ²Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Background: Little is known about the clinical impacts of physical and cognitive impairments on kidney transplantation (KT) candidacy.Methods: We enrolled 170 adults (age> 18 years)…
2018 American Transplant Congress
Comparison of Glycemic Control in Type 1 and Type 2 Diabetic Patients after Pancreas Transplantation
O. Andacoglu,¹ A. Murthy,² J. Ahn,³ J. Verbesey,¹ S. Ghasemian,¹ M. Cooper,¹ P. Abrams.¹
¹Transplant, Medstar Georgetown Transplant Institute, Washington, DC; ²School of Medicine, Georgetown University, Washington, DC; ³Biopstatistics, Georgetown University, Washington, DC.
Background: Pancreas transplant remains controversial for type 2 diabetic (T2DM) patients.Aim: To compare glycemic control following pancreas transplantation between T1 and T2 DM patients.Methods: 52…
2018 American Transplant Congress
Age Stratified Efficacy and Safety Outcomes of Induction Immunosuppression in Renal Transplantation
D. McKimmy,¹ H. Kuzaro,² S. Sakya,³ K. Belfield,¹ E. Cohen.¹
¹Solid Organ Transplant, Yale New Haven Hospital, New Haven, CT; ²University of St. Joseph School of Pharmacy, West Hartford, CT; ³University of Connecticut School of Pharmacy, Storrs, CT.
Purpose: Rejection and infection remain a leading concern for decreased graft survival after renal transplant (RT). Induction immunosuppression is associated with a decreased risk of…
2018 American Transplant Congress
Intention to Treat Outcomes of Patients with Hepatocellular Carcinoma Downstaged to within Milan
P. Tabrizian,¹ M. Holzner,¹ J. Emond,² S. Florman,¹ R. Brown,² M. Schwartz,¹ K. Halazun.²
¹Transplant, RMTI/Mount Sinai, New York, NY; ²Transplant, New York Presbyterian Hospital, New York, NY.
Objectives: The success of LRT has served as a tool to select a subgroup of patients exceeding transplant criteria but potentially achieving meaningful outcome with…
2018 American Transplant Congress
A Novel Combined Formula to Direct Optimal Immunosuppressive Drug Exposure in Renal Transplant Recipients
O. Pankewycz,¹ E. Onan,² M. Laftavi,¹ R. Gruessner,³ H. Smileuski,¹ E. Alissandrello,¹ A. Gruessner.³
¹Upstate Medical University, Syracuse, NY; ²Cukurova University, Adana, Turkey; ³Downstate Medical University, New York, NY.
Purpose: The most widely used maintenance immunosuppressive combination after kidney transplantation is tacrolimus (TAC) and mycophenolic acid (MPA). The utility of therapeutic drug monitoring for…
2018 American Transplant Congress
Impact of Aortic Abdominal Calcification among Living Donor Liver Transplant Recipients; a Retrospective Study
Y. Imaoka, M. Ohira, S. Simizu, H. Tahara, K. Ide, Y. Tanaka, H. Ohdan.
Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.
Abdominal aortic calcification (AAC) is known as a risk factor of coronary artery disease, stroke, hyperphosphatemia, chronic inflammation, diabetes, and decreased an estimated glomerular filtration…
2018 American Transplant Congress
A Novel, Dose-Adjusted Tacrolimus Intrapatient Variability Model Identifies High-Risk Kidney Transplant Recipients Better Than Existing Methodologies
J. Kim, S. Wilson, Y. Song, J. Schwartz.
Astellas Pharma Global Development, Inc., Northbrook.
Intrapatient variability (IPV) of tacrolimus trough concentration (TTC) is a risk factor for inferior transplant outcomes. However, assessing IPV is problematic, relying on fixed dose…